Lataa...

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin

Suberoylanilide hydroxamic acid (SAHA) is a potent inhibitor of histone deacetylases (HDACs) that causes growth arrest, differentiation, and/or apoptosis of many tumor types in vitro and in vivo. SAHA is in clinical trials for the treatment of cancer. HDAC inhibitors induce the expression of less th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Butler, Lisa M., Zhou, Xianbo, Xu, Wei-Sheng, Scher, Howard I., Rifkind, Richard A., Marks, Paul A., Richon, Victoria M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The National Academy of Sciences 2002
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC129332/
https://ncbi.nlm.nih.gov/pubmed/12189205
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.182372299
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!